Wang Y - Search Results

1

A Cancer Nanovaccine Based on an FeAl-Layered Double Hydroxide Framework for Reactive Oxygen Species-Augmented Metalloimmunotherapy.

Chang M, Wang M, Liu B, Zhong W, Jana D, Wang Y, Dong S, Antony A, Li C, Liu Y, Zhao Z, Lin J, Jiang W, Zhao Y. Chang M, et al. Among authors: wang y, wang m. ACS Nano. 2024 Mar 19;18(11):8143-8156. doi: 10.1021/acsnano.3c11960. Epub 2024 Mar 4. ACS Nano. 2024. PMID: 38436248

2

Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy.

Yuan H, Jiang W, von Roemeling CA, Qie Y, Liu X, Chen Y, Wang Y, Wharen RE, Yun K, Bu G, Knutson KL, Kim BYS. Yuan H, et al. Among authors: wang y. Nat Nanotechnol. 2017 Aug;12(8):763-769. doi: 10.1038/nnano.2017.69. Epub 2017 May 1. Nat Nanotechnol. 2017. PMID: 28459470

3

Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions.

Wang Y, Deng W, Li N, Neri S, Sharma A, Jiang W, Lin SH. Wang Y, et al. Front Pharmacol. 2018 Mar 5;9:185. doi: 10.3389/fphar.2018.00185. eCollection 2018. Front Pharmacol. 2018. PMID: 29556198 Free PMC article. Review.

4

Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non-Small Cell Lung Cancer.

Wang Y, Li N, Jiang W, Deng W, Ye R, Xu C, Qiao Y, Sharma A, Zhang M, Hung MC, Lin SH. Wang Y, et al. Clin Cancer Res. 2018 Nov 15;24(22):5744-5756. doi: 10.1158/1078-0432.CCR-18-1489. Epub 2018 Aug 1. Clin Cancer Res. 2018. PMID: 30068711

5

The Reciprocity between Radiotherapy and Cancer Immunotherapy.

Wang Y, Liu ZG, Yuan H, Deng W, Li J, Huang Y, Kim BYS, Story MD, Jiang W. Wang Y, et al. Clin Cancer Res. 2019 Mar 15;25(6):1709-1717. doi: 10.1158/1078-0432.CCR-18-2581. Epub 2018 Nov 9. Clin Cancer Res. 2019. PMID: 30413527 Free PMC article. Review.

6

Tumor Vasculatures: A New Target for Cancer Immunotherapy.

Liu Z, Wang Y, Huang Y, Kim BYS, Shan H, Wu D, Jiang W. Liu Z, et al. Among authors: wang y. Trends Pharmacol Sci. 2019 Sep;40(9):613-623. doi: 10.1016/j.tips.2019.07.001. Epub 2019 Jul 20. Trends Pharmacol Sci. 2019. PMID: 31331639 Free PMC article. Review.

7

Low-Dose Anti-Angiogenic Therapy Sensitizes Breast Cancer to PD-1 Blockade.

Li Q, Wang Y, Jia W, Deng H, Li G, Deng W, Chen J, Kim BYS, Jiang W, Liu Q, Liu J. Li Q, et al. Among authors: wang y. Clin Cancer Res. 2020 Apr 1;26(7):1712-1724. doi: 10.1158/1078-0432.CCR-19-2179. Epub 2019 Dec 17. Clin Cancer Res. 2020. PMID: 31848190 Clinical Trial.

8

Assessment of Trends in Second Primary Cancers in Patients With Metastatic Melanoma From 2005 to 2016.

Deng W, Wang Y, Liu X, Liu J, Wang L, Yang Z, Yang M, An Y, Tang C, Sanford NN, Kim BYS, Jiang W. Deng W, et al. Among authors: wang l, wang y. JAMA Netw Open. 2020 Dec 1;3(12):e2028627. doi: 10.1001/jamanetworkopen.2020.28627. JAMA Netw Open. 2020. PMID: 33295975 Free PMC article.

9

Considerations for designing preclinical cancer immune nanomedicine studies.

Jiang W, Wang Y, Wargo JA, Lang FF, Kim BYS. Jiang W, et al. Among authors: wang y. Nat Nanotechnol. 2021 Jan;16(1):6-15. doi: 10.1038/s41565-020-00817-9. Epub 2020 Dec 21. Nat Nanotechnol. 2021. PMID: 33349682 Free PMC article. Review.

10

Immunocyte Membrane-Coated Nanoparticles for Cancer Immunotherapy.

Gong P, Wang Y, Zhang P, Yang Z, Deng W, Sun Z, Yang M, Li X, Ma G, Deng G, Dong S, Cai L, Jiang W. Gong P, et al. Among authors: wang y. Cancers (Basel). 2020 Dec 30;13(1):77. doi: 10.3390/cancers13010077. Cancers (Basel). 2020. PMID: 33396603 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

292,565 results

Search Page

Filters